Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022

SELL
$5.13 - $9.2 $3,257 - $5,842
-635 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$15.92 - $20.3 $29,658 - $37,818
-1,863 Reduced 74.58%
635 $11,000
Q3 2020

Nov 17, 2020

SELL
$13.97 - $21.16 $4,218 - $6,390
-302 Reduced 10.79%
2,498 $47,000
Q3 2020

Nov 13, 2020

BUY
$13.97 - $21.16 $4,218 - $6,390
302 Added 12.09%
2,800 $53,000
Q2 2020

Aug 17, 2020

BUY
$10.39 - $16.07 $25,954 - $40,142
2,498 New
2,498 $34,000
Q4 2017

Feb 09, 2018

SELL
$3.9 - $4.66 $7,800 - $9,320
-2,000 Closed
0 $0
Q3 2017

Nov 09, 2017

BUY
$4.14 - $5.12 $8,280 - $10,240
2,000
2,000 $9,000

Others Institutions Holding XBIT

About XBiotech Inc.


  • Ticker XBIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,439,300
  • Market Cap $203M
  • Description
  • XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...
More about XBIT
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.